State Board Of Administration Of Florida Retirement System X4 Pharmaceuticals, Inc Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 09, 2024	BUY	$0.61 - $0.99 $19,507 - $31,659	31,979 New	31,979 $26,000
Q2 2023 Aug 11, 2023	BUY	$0.82 - $2.49 $28,659 - $87,025	34,950 New	34,950 $67,000

Others Institutions Holding XFOR

# of Institutions

103

Shares Held

99.9M

Call Options Held

213K

Put Options Held

50.6K

Bain Capital Life Sciences Investors, LLC Boston, MA

16.9M
Shares

$10.3 Million
2.03% of portfolio
Nea Management Company, LLC Timonium, MD

15M
Shares

$9.14 Million
0.77% of portfolio
Black Rock Inc. New York, NY

10.7M
Shares

$6.51 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.44M
Shares

$5.15 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

7.13M
Shares

$4.35 Million
0.11% of portfolio

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $41.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account